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ABSTRACT : Federal legislation that has been introduced to amend the Social Security Act in order to
provide for coverage of cognitive pharmacist services under the Medicare program in medically underserved
communities. In the rural state of Arkansas this legislation would be well-received because a large portion of
the state meets the criteria of a health professional shortage area. Considering the growing interest of using
telecommunications as an alternative means of delivering healthcare services to medically underserved rural
areas, a pharmacist-staffed consumer-oriented drug information service was explored. Over a 5-day period,
473 face-to-face consumer surveys were conducted in pharmacy and non-pharmacy settings in an urban cluster
population center that serves the surrounding rural area. The survey was designed to determine whether or not
consumers had a perceived need for a drug information service that was independent from and supplemental to
services provided by their pharmacist. Results reveal that 71% of participants surveyed did not perceive a need
for medication information that was supplemental to that provided by their pharmacist. When queried regarding
the likelihood of using a drug information service if one was available their response was neutral, and they
became less likely if a fee was associated with the service. While the results are not conclusive and cannot be
generalized as to whether a consumer-oriented drug information service would contribute to improving patient
care, the survey suggests that this telepharmacy service is not perceived as being needed by the public.

KEYWORDS – Consumer medication information, Drug information center, Patient education, Telepharmacy
I. INTRODUCTION
Under federal law in the United States, despite their extensive education and training on the use
of drug therapy, pharmacists are not recognized as healthcare providers. While strides have been made
to recognize pharmacists at the state level, this lack of provider status has severely limited pharmacists’
formal contribution to improving patient care. On March 11, 2014, H.R. 4190 was introduced in the
United States House of Representatives, legislation that would amend the Social Security Act to provide
for coverage of cognitive (non-drug product) pharmacist services under the Medicare program in
medically underserved communities (i.e. settings located in a health professional shortage area, medically
underserved area, or medically underserved population).[1]
Arkansas, situated in the southern United States, is a state with 75 counties that has a largely
rural population (45%). All or parts of 73 counties have been identified as medically underserved, while
55 counties have officially designated health professional shortage areas.[2] Recent statistics show there
are 867 residents in Arkansas for every one primary care doctor, whereas in the U.S. overall there are 631
residents for every one primary care doctor.[3] In contrast, in Arkansas there are approximately 4,500
pharmacists represented in all 75 counties which equates to a favorable 658 residents for every one
pharmacist.[4] Clearly, legislation that affords pharmacists provider status coupled with the size and
distribution of the pharmacist workforce could help meet the needs of patients in rural Arkansas.
As a means of delivering pharmacy services in medically underserved rural areas, some states
have seen the development and implementation of telepharmacy services. While the provision of
pharmacy services via telecommunications has been described to include a variety of clinical and
dispensing functions, in Arkansas it has principally revolved around remote order entry with drug
regimen review in a hospital setting.[5,6] One service that would be readily adaptable to a telepharmacy
application and could be provided on a large scale are pharmacist-based drug information services.
Drug information centers have been a staple in pharmacy practice since their inception.
However, their traditional role has been principally focused on serving healthcare providers, almost to
the exclusion of consumers. The objective of this survey was to explore the perceived need for a
consumer-oriented drug information telepharmacy service that is unrelated to pharmacy dispensing
services in rural Arkansas.
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II. METHODS
We conducted face-to-face consumer surveys over a 5-day period in an urban cluster population
center of approximately 21,000 inhabitants which serves as the economic epicenter for the surrounding
rural area.[7] Survey participants were recruited from both pharmacy and non-pharmacy settings,
including six chain pharmacies, five independent pharmacies, and two non-pharmacy commercial
establishments. All unique respondent identifiers were purged from the aggregate data upon completion
of data collection and prior to analysis. This survey received an exempt status from the Harding
University institutional review board. Participation was voluntary without inducement and informed
consent was given.
Upon agreeing to participate in the survey, the purpose of a consumer-oriented drug information
service was first described to each respondent as: “The purpose of a drug information service is to
answer your medication-related questions by providing you with objective, unbiased information in an
effort to promote safe and cost-effective medication use.” Then, participants were administered a 2-3
minute survey designed to determine whether or not consumers had a perceived need for a drug
information service that was independent from and supplemental to services provided by their
pharmacist. The survey instrument consisted of a combination of five closed-ended, Likert scaled, and
multiple-choice questions. On a scale of 1 to 5, with 1 being highly-likely and 5 being highly-unlikely,
participants were asked regarding the probability that they would use a consumer-oriented drug
information service if one were available, and separately the probability that they would use the service if
a fee was involved. Finally, the survey collected information on the types of drug-related questions the
consumer would most commonly have, as well as the preferred method by which the consumer could
pose and receive responses to information requests. Descriptive statistics were compiled expressing
results as percentages for each question in the survey.

III. RESULTS
A total of 473 participants provided evaluable responses to the survey (Table 1). The total
number of surveys completed was nearly evenly distributed across pharmacy (n=252, 53%) and nonpharmacy (n=221, 47%) settings. However, more individuals participated in the survey from a chain
pharmacy setting (179, 71%) when compared to an independent pharmacy setting (73, 29%).
Table 1.

Perceived Need for Consumer-Oriented Drug Information

Survey Setting
All Settings Combined
Pharmacy
Independent
Chain Drugstore
Non-Pharmacy

#
Respondents
473

Information Needed
Yes
No
135 (29%)
338 (71%)

252
73
179
221*

64 (25%)
17 (23%)
47 (26%)
71 (32%)

188 (75%)
56 (77%)
132 (73%)
150 (68%)

*Two participants in a non-pharmacy setting did not answer this question

When asked “Do you have a need personally for information about your medication that would
supplement information provided by your pharmacist?”, overall only 29% responded in the affirmative
with the vast majority (71%) indicating they did not have a personal need. When responses were
separated according to survey setting (see Table 1), there was a slightly greater perceived need by
participants queried in a non-pharmacy setting (32%) versus those asked inside a pharmacy (25%).
Table 2.

Consumer's Likelihood of Using a Drug Information Center
(Scaled Response: 1 = Highly-Likely to 5 = Highly Unlikely)
Mean
Survey Setting
# Respondents
Response
All Settings Combined
472
2.9
Pharmacy
Independent
Chain Drugstore

249
72
177

3.0
2.9
3.1

Non-Pharmacy

223

2.8

*Three participants in a pharmacy setting did not answer this question
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In response to the question “How likely would you be to use a consumer-accessible drug information
service?”, the overall mean response on a scale of 1–5 was an ambivalent 2.9 (mean = 3, mode = 3; see Table 2).
It was expressed by some respondents that this type service might be beneficial to access at a time their
pharmacy was closed. Participants were even less receptive to the concept when asked “How likely would you
be to use a consumer-accessible drug information service if there was a fee for the service?”, with an overall
mean response on a scale of 1–5 of 3.5 (see Table 3).
Table 3.

Consumer's Willingness to Pay for Drug Information Services

Survey Setting

# Respondents

Mean

Median

All Settings Combined

472

3.5

4

Pharmacy

251

3.7

4

Independent

73

3.5

4

Chain Drugstore

178

3.7

4

221

3.2

3

Non-Pharmacy

*Three survey participants across all survey settings did not answer this question
Summarized in Table 4 are the preferred modes of access if respondents were inclined to use a
consumer-oriented drug information service. Finally, the types of drug-related questions consumers anticipated
they would most commonly ask are depicted in Fig. 1.
Table 4. Preferred Mode of Access
Survey Setting

%

Telephone

35%

Online Submission

30%

Live Conversation
US Mail
Fax

18%
15%
2%

* Four participants in a pharmacy setting
did not answer this question

Fig. 1

Types of drug information most commonly anticipated
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IV.

DISCUSSION

A strict interpretation of the results indicates the public: (1) does not perceive there to be a need for an
independent consumer-oriented drug information service that is not connected in some way with their
pharmacy-related services; (2) is ambivalent in terms of their likelihood of using a service if one were available;
and (3) would further be less likely to use a service if a fee was involved. These results, while somewhat
surprising, remain valuable because absent a reason that compels them to do so, it is clear the public is not likely
to voluntarily access the resources of a consumer-oriented drug information service. Beyond this, the results
perhaps raise more questions than they provide answers.
Although a measure of satisfaction was not factored into the survey, the results could indicate the
respondents’ drug information needs were being adequately met by their pharmacist. Alternatively, there could
be some sampling bias related to location because more than half the surveys were taken inside a pharmacy.
However, any effect the location had on the responses was small because, even though there was a tendency for
non-pharmacy participants to have a greater perceived need for consumer-oriented drug information services,
the different between settings was <10%. Finally, cost should not have been a factor in influencing answers to
the other questions because the question related to fee-based services was the last question asked.
Despite the survey findings, it is known that the majority of patients have unmet drug information
needs and the lack of awareness about proper medication use and associated risk factors has been identified as
potentially accounting for some rural health disparities.[8] This is evidenced by poor medication adherence and
issues with drug safety, problems that are only compounded in patients living in medically underserved areas.
Several key medication-related health needs in residents in rural Arkansas have been identified. Arkansans have
been shown to have a high prevalence of heart disease, stroke and diabetes, chronic disease states that require
intensive pharmacotherapy. With respect to health maintenance, Arkansas has an adolescent immunization rate
that is lower than the national average. Further, rural Arkansans are more likely to struggle with low health
literacy.[9] Each of these represents problem areas where pharmacists can use their unique skills to enhance
patients’ health.

V. CONCLUSIONS
Whether or not patients are in the best position to determine whether supplemental drug information is
needed, under the scenario surveyed they would be the ones making the decision to initiate contact with the
service described. While these findings do not speak to whether a consumer-oriented drug information service
would contribute to improving patient care, the survey indicates a consumer-oriented drug information
telepharmacy service is not perceived as being needed by the public.
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